HIF1A and prostate carcinoma: Park et al. demonstrated that phosphorylation of p70S6K activation was inhibited secondary to melatonin treatment, which resulted in decreased HIF-1α expression in DU145, PC3, and LNCaP prostate cancer cell lines.